⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma

Clinical trial NCT03107663 · COMPLETED

Trial details

NCT number: NCT03107663
Sponsor: ImaginAb, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Positron-Emission Tomography Immunomodulation Metastatic Solid Malignancies Hodgkin Lymphoma

Start date: 2017-06-19
Primary completion: 2018-08-16
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.